http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104105508-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L71-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G83-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-33396 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-33303 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
| filingDate | 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104105508-B |
| titleOfInvention | The enhanced end dendritic of medicine delivery |
| abstract | The invention provides amphipathic end dendritic, its aggregation is characterized as the nano-carrier of hydrophobic core and hydrophilic exterior to be formed.The nano-carrier core may include amphipathic degree of functionality, such as cholic acid or chlolic acid derivatives, and the outside may include branched or linear PEG fragment.Nano-carrier loading, such as hydrophobic drug and other materials, can be isolated in the core via non-covalent means, or can be with the end dendritic construction unit covalent bond.End dendrimer structure can change load performance, the interaction with the material of such as biomembrane and other characteristics with adjusted. |
| priorityDate | 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.